April 19, 2010 – The Fibroid Treatment Collective (FTC) has launched an annual observance called Fibroid Awareness Week scheduled this year for April 19-23, which is dedicated to education about fibroids that affect upwards of 50 percent of all women.
Concern for the high number of unnecessary hysterectomies and dissatisfaction with other treatment outcomes led Bruce McLucas, M.D., founder of the collective and a board certified obstetrician and gynecologist, to become a non-surgical treatment advocate. His goal, and the mission of FTC, is to ensure women with fibroids know all the options when it comes to treatment. FTC advocates embolization as a safe alternative to other fibroid treatments.

In gynecology, embolization is used to reduce bleeding during uterine surgery. Founding members of the Fibroid Treatment Collective also noticed it shrinks fibroids. The promise of an effective, noninvasive treatment led to research, trials and medical acceptance. Today more than several hundred thousand women world-wide have found relief with this safe, simple procedure. The Fibroid Treatment Collective performed the very first fibroid embolization in America, and has perfected the procedure with thousands of successful treatments to date. Dr. McLucas is one of the only gynecologists in America accredited in the skills necessary to perform embolization.

Several special events will highlight the week, including a Fibroid Treatment Seminar on Wednesday, April 21 in Pasadena, Calif., at 6:00 p.m. and a national Fibroid Treatment Webinar, at 5 p.m., Friday, April 23. Both are free, and reservations can be made at www.fibroids.com.

Uterine fibroids can affect women of all ages, but are most common in women ages 40 to 50. “We felt the best way to reach out to almost half the women around the world who may have symptoms of fibroids was through an annual educational observance and to disseminate accurate and timely information about diagnosis and treatment,” said McLucas. “The Fibroid Treatment Collective was founded 12 years ago to educate women about fibroids and various treatment options,” he added.

Women interested in learning more about Fibroid Awareness Week can join a national live chat Monday through Friday from 9 a.m. - 5 p.m. PST at www.fibroids.com.

For more information: www.fibroids.com


Related Content

News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
News | Artificial Intelligence

Dec. 2, 2024 — Lunit recently unveiled follow-up findings from the ScreenTrustCAD trial. This study, conducted at Capio ...

Time December 02, 2024
arrow
Subscribe Now